
For Cannabis Cultivators, Processors, Manufacturers & Retailers
Executive benefits intelligence built for cannabis employers.
Healthcare is one of the largest operating expenses for many cannabis businesses. The Cannabis Benefits Optimization Report (CBOR™) is a proprietary, data-led assessment combining financial optimization, cannabis industry intelligence and, where sufficient data is available, clinical and predictive analytics, so leadership can make informed decisions about one of its largest operating expenses.
Let’s determine whether a Cannabis Benefits Optimization Report™ makes sense for your organization.
Why Cannabis Employers Are Different
Cannabis organizations operate under conditions most benefits benchmarks never contemplated. The result can be a plan priced on assumptions that do not match the workforce actually enrolled in it.
Headcount can double inside a plan year. Benefit structures built for 30 employees rarely fit 120 without a financial reset.
Turnover can distort claims experience, enrollment assumptions and the renewal math carriers build around a group.
Corporate, retail, cultivation, extraction, manufacturing and distribution roles rarely behave like a single employee population.
Part-time and variable-hour dispensary staff create eligibility, affordability and participation questions many plans handle poorly.
Operating across state lines can multiply plan design, leave and reporting obligations for a small internal HR team.
Benefits can be a visible differentiator when competing for cultivation leads, extraction technicians and experienced managers.
Medical and pharmacy trend compounds on a base that was often set without claims-level analysis in the first place.
Comparing a multi-state operator to a generic manufacturing or retail benchmark can produce conclusions that do not hold up.
Your employee benefits strategy should reflect the realities of your industry.
The CBOR™ Framework
Goal
Identify where benefit dollars are going and where financial efficiency may be improved.
Evaluated where sufficient data is available:
Goal
Move beyond historical claims reporting toward understanding what may drive future healthcare costs.
Goal
Evaluate the benefits program in the context of how a cannabis company actually operates.
Translate the analysis into:
Goal
Turn complex benefits data into an executive-level decision framework.
Let’s determine whether a Cannabis Benefits Optimization Report™ makes sense for your organization.
What Leadership Receives
A comprehensive analysis of the employer’s current benefits program, financial performance, risks, benchmarking and optimization opportunities.
A condensed leadership-level presentation highlighting the most important findings, financial opportunities, strategic considerations and recommended priorities.
The findings can be reviewed with leadership during an executive presentation designed for approximately 60 minutes. The goal is not to overwhelm leadership with benefits data. The goal is to turn the data into decisions.
Limited Industry-Specific Benchmarking
Traditional employee benefits benchmarks rarely isolate cannabis employers by workforce type, operating model, geography and funding structure.
CBOR™ evaluates available benchmarking through a cannabis-specific lens while also considering relevant comparisons across retail, manufacturing, agriculture and other industries with similar workforce characteristics.
The objective is not simply to determine whether costs are above or below an industry average. The objective is to determine whether the employer’s benefit dollars are being deployed efficiently.
Workforce & Operational Risk
Cannabis employers can have unusually diverse employee populations spanning corporate, retail, cultivation, extraction, manufacturing, distribution and field operations.
Cultivation, trimming, extraction and manufacturing roles can create ergonomic, repetitive-motion and workplace exposure considerations that should be evaluated differently from traditional office-based populations.
CBOR™ examines how workforce composition, geography, turnover, compensation and operating environment may influence benefit utilization, plan design and overall healthcare strategy.
Clinical Risk & Population Health Intelligence
Where sufficient data is available, CBOR™ can incorporate advanced clinical and predictive analytics to help leadership better understand the health risks developing within the covered population.
All healthcare information should be evaluated using appropriate aggregated and population-level data. The purpose is to identify trends and opportunities, not to provide executives with individually identifiable employee health information.
Availability and depth of predictive analytics depends upon employer size, funding arrangement, data availability and applicable privacy requirements.

Benefits Compliance & Fiduciary Review
Evaluate areas of potential benefits-related compliance, governance and fiduciary exposure, including applicable transparency requirements, vendor arrangements, plan documentation and oversight responsibilities.
CBOR™ is an employee benefits optimization assessment and is not intended to provide legal, tax or cannabis regulatory advice.
Strategies That May Be Evaluated
Depending upon what the data reveals, potential strategies may include:
We do not begin with a predetermined solution. The data determines which strategies deserve further evaluation.
Cannabis Industry Strategic Partnerships
CBOR™ is designed to complement the banking, financial and advisory relationships cannabis operators already rely upon.
Through strategic relationships within the cannabis ecosystem, qualifying employers may be introduced to an independent employee benefits optimization assessment designed specifically around the financial, workforce and operational realities of the cannabis industry.
The objective is simple: give leadership a clearer understanding of where benefit dollars are going, where unnecessary cost or risk may exist, and what opportunities deserve further evaluation.
No immediate broker change or purchasing decision is required to complete the assessment.
Strategic partnership programs and eligibility may vary.
The Process
A short call to confirm fit, current structure and renewal timing.
Plan documents, funding detail and available claims data under a mutual NDA.
Financial modeling, benchmarking and population-level health review.
A written CBOR™ plus a board-ready executive summary.
An executive read-out with leadership, designed for approximately 60 minutes.
Leadership reviews the prioritized roadmap and determines which opportunities deserve further evaluation.
There is no obligation to make a change.
The purpose of the CBOR™ is to give leadership an independent, data-supported view of the current benefits strategy and a prioritized roadmap for what should happen next.
If the analysis validates the current strategy, leadership gains confidence. If opportunities are identified, leadership receives a clearer understanding of their potential financial and strategic impact before deciding how to proceed.
The assessment comes first. The decision comes second.
Who Should Request a CBOR™
Next Step
Healthcare is one of the largest and fastest-growing operating expenses for many employers.
Cannabis companies deserve an assessment that considers their industry, workforce, financial structure and future growth, not simply another insurance quote.
CBOR™ provides leadership with an independent, data-led view of the current program and a roadmap for what should happen next.
Start with a 20-minute conversation.
Or request more information: brian@brianpinto.com
CBOR™ is the Cannabis Benefits Optimization Report developed by Brian Pinto. Services are provided through Brian’s affiliated employee benefits consulting firm. Advanced clinical and predictive analytics may be incorporated where sufficient data is available. CBOR™ is an employee benefits optimization assessment and does not provide legal, tax or cannabis regulatory advice.